BACKGROUND: Demyelination is a core pathological feature of multiple sclerosis (MS) and spontaneous remyelination appears to be an important mechanism for repair in the disease. Magnetization transfer ratio imaging (MTR) has been used extensively to evaluate demyelination, although limitations to its specificity are recognized. MT saturation imaging (MTsat) removes some of the T1 dependence of MTR. We have performed a comparative evaluation of MTR and MTsat imaging in a mixed group of subjects with active MS, to explore their relative sensitivity to pathology relevant to explaining clinical outcomes. 
Introduction
Multiple sclerosis (MS) produces both inflammatory and degenerative pathology in the brain and spinal cord. Conventional magnetic resonance imaging (MRI) of the brain is highly sensitive for detecting focal inflammatory lesions in patients with MS. Assessments of the burden of brain T2 lesions are used to monitor evolution of MS clinically. However, only modest correlations between brain MRI lesion load and clinical disability have been found. 1 One explanation for this is that comprehensive detection of lesions in spinal cord MRI still is more challenging than for the brain although occurrence of MS lesions in the cord is believed to give rise to clinical symptoms more often than lesions located in the brain. 2, 3 The assessment of MS pathology using T2-weighted images is also limited by the poor specificity of this technique to the heterogeneous substrates of MS lesions, 4 and by its inability to provide information about the microscopic changes occurring in the normal appearing white matter (NAWM). 5 Perhaps, most important, however, is that substantial neuronal and axonal loss are found in the brain and spinal cord, in addition to demyelination. [6] [7] [8] [9] [10] Magnetization transfer imaging (MTI) provides quantitative metrics sensitive to microstructural changes reflecting some neurodegenerative aspects of MS pathology that, 11, 12 in conjunction with conventional MRI measures, allow the combined macroscopic and microscopic disease burdens to be estimated. 13 More specifically, MTI reflects the exchange of magnetization between freely mobile protons and those associated with macromolecules in myelin or axonal membranes.
The alternative approach of quantitative MT saturation (MTsat) offers a measure that, unlike MTR, is minimally affected by T1 relaxation and is less sensitive to B1 inhomogeneities. WM to gray matter (GM) contrast in MTsat maps is increased relative to that in MTR maps. 16 MTsat thus may enhance insights into clinicopathological correlations related to changes in the cervical cord in MS relative to the MTR.
The goals of this study are to compare MTR and MTsat measures across an MS population and to analyze their capability to discriminate between disability levels when they are applied to the brain and cervical spinal cord of a cohort of 134 patients. Correlations between MTR and MTsat histogram metrics of the brain and the cervical cord and disability were explored.
Methods Patients
The cohort of patients formed part of the Patient Research Cohort Rapidly Evolving Multiple Sclerosis Study (PRC-REMS), which had the approval of the London-Chelsea Regional Ethics Committee (NCT01044576) and was conducted in accordance with the principles of Good Clinical Practice (GCP). MRI scans of the brain and cervical spine for 134 patients were available for this study. The degree of disability was estimated according to the Kurtzke's Expanded Disability Status Scale (EDSS) and the timed 25-foot walk (T25FW) scale from the Multiple Sclerosis Functional Composite.
MRI Acquisition
The study was performed on a 3T clinical MR system (Magnetom Verio, Siemens Medical Solutions, Erlangen, Germany). A combined head and neck radiofrequency (RF) coil system consisting of a 12-channel phased array head coil and four-channel phased array neck coil was used for reception. The system body coil was used for all excitation and MT RF pulses, and no repositioning occurred between sequences. Pre-and postcontrast T1-weighted 3-dimensional (3D) Magnetization Prepared Rapid Gradient Echo (MPRAGE) volumes were acquired similarly to the Alzheimer's Disease Neuroimaging Initiative-recommended parameters except 1 mm isotropic resolution, 17 parallel imaging (PI) factor of 2, and 256 × 192 mm field of view (FOV) in 5 m:21 seconds in the brain. A .6 × .6 × 2.0 mm resolution and 160 × 160 × 160 mm FOV were used in the cervical spinal cord in 3 m:43 seconds. A physician injected gadolinium contrast (Gadoterate meglumine, Dotarem, Guerbet, .1 mmol/kg) 5 minutes before the acquisition of the final image volumes: the postcontrast MPRAGE volumes of the brain and c-spine. All other images were acquired before the contrast injection. T2-weighted fluid-attenuated inversion recovery (FLAIR) volumes were acquired with 1 mm isotropic resolution and 160 sagittal sections in a single 3D slab, 250 × 250 mm FOV, PI factor of 2, inversion time (TI) 1,800 ms, repetition time (TR) 5 seconds, and echo time (TE) 395 ms, in 5 m:52 seconds in the brain. A 3D fast low-angle shot (FLASH) sequence with 1 mm isotropic resolution, 192 sagittal partitions, and 256 × 240 FOV was employed in the brain (with a readout in the head-feet direction with 600 Hz/pixel bandwidth to reduce susceptibility artifacts). Six monopolar gradient echoes equally spaced between TE of 1.95 and 11.7 ms were acquired during a TR of 27 ms. A PI factor of 2 was used for the GRAPPA parallel acquisitions. A flip angle of 5°was chosen for the proton density-weighted (PD-w) dataset, meanwhile another was MT-weighted by a band selective RF pulse of Gaussian shape with a duration of 12.24 ms, 2.2 kHz frequency offset, and nominal 540°flip angle, in 7 m:20 seconds. A T1-weighted volume, similar to the PD-w but with a TR of 15 ms and a flip angle of 18°, was also acquired in 4 m:05 seconds. A similar set of three contrasts at 1 mm isotropic resolution was acquired in the cervical spinal cord, but with a smaller FOV of 192 × 156 × 120 mm. The PD-w and MT-weighted acquisitions used a TR of 26 ms, requiring 4 m:59 seconds each. The T1-weighted volume used a TR of 13 ms and flip angle of 15°. Other parameters remained the same as the brain acquisitions.
Data Analysis
MTR maps were produced on a voxel by voxel basis according to the equation:
where M s and M 0 are signal intensities with application of saturation pulse and without respectively. MTR values are reported in percent units (p.u.). The MTsat parameter was calculated by inserting the estimated A app and T 1app values in the approximate signal equation for the MT FLASH experiment. 18 The MTsat parameter represents the additional percentage reduction in the steady-state FLASH signal caused by the saturation effect of a single MT pulse. It is calculated from this equation:
Using A app and T 1app obtained from these equations:
MTsat has been shown to be insensitive to inhomogeneities in RF transmit field and receive fields. 16 Unlike MTR, the MTsat is not affected by T1 relaxation.
SIENAX from FSL was used on T1-weighted images in the extraction of the brain and segmentation of GM and WM using a partial volume of threshold of .70 and estimation of their volumes. 19 The cervical cord, brain WM lesions, and cervical spinal cord lesions were extracted manually with Analyze 11.0 (AnalyzeDirect/Mayo Clinic, KS). For each region, intensity distribution maps for segmented MTsat and MTR were calculated by Matlab (Mathworks Natick, MA) and histograms were generated for each subject with bins of width .25 p.u. 20 The histogram median and height of the highest peak were recorded. Linear coregistration of datasets was performed using FLIRT. 21 Volumes were normalized with intracranial volume (ICV) to reduce interindividual variation. Intersubjects coefficients of variation (CoV) were calculated:
Spearman rank-order correlation coefficient and Spearman's partial correlations (controlling for age, gender, and disease duration) assessed associations between volumes, MTR and MTsat histogram median and peak height, and both EDSS and T25FW.
Mixed models with patient as a random factor were calculated after the imputation of missing values. They determined the correlation between magnetization transfer histogram metrics and the volumes (segmented lesions, brain, and cord) with disability scales EDSS and T25FW. Parameter estimates and marginal means with 95% confidence intervals were presented.
A two tailed P value less than .05 was considered significant and corrected thresholds for P were applied for multiple comparisons. All statistical analyses were performed with SPSS for Windows (v. 17, SPSS Inc., Chicago, IL) except the comparison of correlations, which was done with the cocor package.
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Results
Subjects included people with both relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) ( Table 1) . T1 lesions or T2 hyperintensities in the FLAIR volumes were identified in 121 cases. Cervical T2 lesions were identified in 19 subjects. 121/123 datasets met blinded image QC criteria.
Manual spinal cord segmentation was performed in 52 subjects. The MTsat maps showed higher contrast between WM, GM, and cerebrospinal fluid (CSF) relative to the MTR maps. The average histograms for the whole brain and for WM, GM, and CSF for the cohort of patients illustrate this ( Figs 1A and  B) ; the MTR histogram did not show a clear mode for the CSF. The MTsat peak height in the brain parenchyma was correlated with the MTR peak height (r = .590; P < .001). This was not found for CSF (r = .122; P = .188). Segmentation of the spinal cord into WM and GM was not performed for tissue-specific analyses in the spinal cord.
Both whole-brain MTR and MTsat were correlated with median WM lesion (WML) volumes (r = .654, P < .001 for MTR and r = .491, P < .001 for MTsat), and their comparison showed they were significantly different (z = 2.892; P = .004). Significant correlations were also found between both magnetization transfer and clinical disability measures (EDSS and T25FW) ( Table 2 ). For MTsat, significant correlations were found between median values in NAWM and both EDSS and T25FW. No significant disability correlations were found for median NAWM MTR. Significant correlations were found between the median MTsat and EDSS for all cervical spinal cord regions (Table 3) . No significant correlations were found between median MTR values and either the EDSS or T25FW.
Correlations between MTR and MTsat histogram metrics (median values, peak heights, and location) for the whole brain and either NAWM and the whole cervical spinal cord or the normal appearing spinal cord (NASC) were explored. No correlations were found between MTR or MTsat metrics obtained from the brain and the cervical cord although we found a trend toward a significant correlation (ie, those that reached P < .017, Bonferroni-corrected) between the median whole-brain MTsat and peak height of the whole cervical cord MTsat when controlling for age (r = .348; P = .024).
Mixed model analyses revealed that median and peak height MTsat explained significant amounts of disability measures. In a model with the following variables: age, gender, and metrics (median and peak height) for the whole brain and c-spine, both the median whole-brain MTsat The mixed models did not provide evidence that wholebrain volume or individual (GM or WM) tissue volume fraction measures explained a significant proportion of the disability. Spearman rank-order correlations with EDSS were significant for T2 lesion volume (r = −.254; P = .005), WM (r = .181; P = .048), and GM (r = −.189; P = .038) fractions. 
Discussion
Magnetization transfer provides a potentially useful complement to conventional MRI in assessment of patients with MS. 23 Several studies have shown that MTR values in NAWM are altered in all of the major phenotypes of MS. Reduced MTR values have been found in NAWM, even in patients with clinically definite MS and very few or no T2 visible lesions. 24 Quantitative magnetization transfer (qMT) allows parameters that reflect myelin integrity to be estimated independently of T1 and cross-relaxation rates between bound and unbound proton fractions. 25 However, although qMT has a higher specificity for pathological processes underlying MS and is independent of MRI sequence, it requires long acquisition times and complex postprocessing, which have limited its application to animal models, postmortem, and experimental phase human imaging. 26, 27 MTR provides a measure reflecting microstructural information. 15, 20 In general, MS pathology is associated with a decrease in MTR: low MTR has been found in lesions that were not apparent on conventional MRI. Myelin loss (and, to a smaller extent, edema) reduces MTR values in MS. 21 Several studies have shown that MTR histogram-derived measures of the cervical cord correlate well with the clinical manifestations of MS and are related to demyelination. 23, 28 Our cohort had by definition a low to midlevel EDSS, with a maximum EDSS of 6.0. Other studies have included subjects with higher EDSS, which may explain our failure to identify a correlation between NAWM MTR and disability in this population.
Previous studies found that T2 lesion volume in the brain or spinal cord have not tended to show strong or significant correlations with the EDSS, 1, 29, 30 although, in our population, there was a significant Spearman significant correlation of the brain T2 lesion volume, WM and GM fractions with EDSS. By contrast, we did not find simple correlation between cord volumes with EDSS and T25FW. Failure to identify some associations reported by others may reflect the restricted range of our sample of patients, who were mildly disabled (median EDSS = 3.5), with a well-preserved ambulatory function and shorter disease duration (median disease duration = 2 years).
Studies that involved larger cohorts with a longer disease duration (>20 years) and higher EDSS (median of 4, range 0-8) have reported associations between upper spinal cord cross-sectional area and disability. 31 No significant relationships between brain and cervical cord volumes and MTR/MTsat metrics were found and this suggests a nonuniform disease process in MS. The processes may affect each region independently or show differential involvement between patients. In the brain tissue, axonal transection has been documented at the center and the periphery of demyelinating lesions leading to axonal and tissue volume loss in the adjacent WM, but in a large cross-sectional MRI study and in a postmortem study, no relationship between spinal cord atrophy and brain lesions was found. 28, 32, 33 We hypothesized that MTsat measures, which take into account biophysical variations that may reduce the precision of MTR, may enhance the potential for discovery of clinicopathological correlations related to magnetization transfer. Consistent with this, we found significant correlations between median NAWM MTsat and EDSS and T25FW that were not found for MTR. Similar results were found for the cervical spinal cord, which also showed a correlation between median MTsat values and EDSS, although the same relationship was not found for MTR.
This apparent difference in sensitivity is likely to reflect differences between the two acquisition sequences to biophysical properties of tissue. A major contribution to decreased magnetization transfer in MS arises from reduced myelin volume, although increased tissue water also reduces MTR values in MS through effects on regional T1. 32 Lower axon density (which can vary between people with MS independently of differences in myelin density) also increases tissue T1 recovery time, and can itself decrease MTR. 34 MTsat is relatively insensitive to T1-dependent effects, which are a significant source of variance in the MTR signal; this is likely to account for the greater contrast between tissue compartments seen with MTsat in the population observed here. The significantly lower correlation between MTsat and WML size versus MTR and lesion size that we observed this provides indirect evidence that MTsat is less dependent than MTR on lesion volumes, suggesting that it reflects microstructural damage outside of lesions to a greater extent.
Other studies are necessary to explore the limitations or advantages of MTsat versus conventional MT imaging in MS, preferably with a gold standard for comparison, such as histology from postmortem tissue. This could allow a direct determination of whether the MTsat technique was more sensitive to underlying axonal or cellular loss. Visual inspection of histograms noted that GM, WM, and CSF were much more separated in the MTsat versus MTR histograms. Similarly, the whole cervical spinal cord MTR histogram was unimodal, while that of MTsat was bimodal. A full comparison of the ability of MTR versus MTsat to discriminate tissue type needs to be performed.
The absence of a healthy control cohort is a major limitation of our study. Furthermore, no longitudinal data are available. Comparisons can only be made within the diseased group at a single timepoint. A full study tracking both healthy and MS subjects over time is the next logical step. The manual segmentations in the spinal cord were only performed by a single researcher due to the high labor required; no metrics of interreader reliability are available.
In conclusion, MTsat discriminated between disability levels in MS better than MTR in the NAWM and in the spinal cord in this study population of low to moderate EDSS and short disease duration. We speculate that MTsat may be more sensitive to microstructural tissue damage in MS than is MTR, and may prove useful and practicable for imaging in larger scale clinical studies and therapeutic trials.
